Xcout Intel
Origin competitors & alternatives
The 12 closest competitors and alternatives to Origin among biotech companies — ranked by similarity to what Origin actually does, not by market-cap band.
Subscribe to see Origin’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Origin
Origin Bio operates a tissue-first data and model platform that maps cancer biology using patient tumor samples. The company generates spatial, molecular, and functional maps from real tumor tissue to support target discovery, drug response prediction, and multimodal AI modeling for researchers and life sciences partners.
Origin at a glance
Origin is a biotech company headquartered in United States. It has raised at least $5.5M across the 3 funding rounds on record. Its most recent funding round raised $500,000 in June 2022. Xcout recorded 5 job postings from Origin in the last 90 days.
Origin funding rounds
At least $5.5M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $500,000 | — | |
| SEC Form D filing | $1.3M | — | |
| SEC Form D filing | $3.7M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Origin
Xcout recorded 5 job postings from Origin in the last 90 days, from a hiring record Xcout has kept since May 2026.
The weekly hiring trend, the roles and locations behind it — see Origin's hiring signals →
Top 12 Origin competitors
Ranked by semantic similarity — how close each company is to Origin by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
Parallel Bio provides a human-first drug discovery and precision medicine platform that maps human biology using patient samples and computational tools. The company serves pharmaceutical and biotechnology organizations by conducting faster, animal-free preclinical testing and generating proprietary human biological data.
Biotechnology
Lifesenz Cancer is a biomedical organization that develops 3D cell culture systems and patient-derived ex vivo models to predict individual chemotherapy responses and guide precision cancer therapy. The company also provides biopharmaceutical R&D training, workshops, and educational programs for students, researchers, and job seekers to bridge the gap between academia and industry.
Biotechnology
WittGen Inc. provides a virtual cell-to-patient profiling technology powered by single-cell generative AI for clinical leaders and biopharmaceutical researchers. The company's platform transforms archived bulk RNA samples and pathological image data into regulator-ready patient stratification insights and cellular-level biomarkers to de-risk clinical trials and accelerate oncology drug development.
Similar biotech company
Indivumed GmbH is a precision oncology company that provides tumor and normal tissue samples, multi-omics and clinical data databases, biomathematical and AI tools, and patient-derived cellular models. The company serves researchers and pharmaceutical partners by conducting cancer target discovery, target validation, and therapeutic drug development.
Biotechnology
Tessellate Bio is a biotechnology company that develops precision oncology medicines by exploring synthetic lethal interactions beyond homologous recombination deficiency. The company integrates biomarker discovery and companion diagnostics into its research programs to create first-in-class treatments for hard-to-treat cancers.
Similar biotech company
Blank Bio is an applied AI research lab founded in 2025 and headquartered in San Francisco, California. The company builds RNA foundation models to learn patterns linked to disease, providing RNA intelligence for precision oncology and medicine.
Biotechnology
Impact Proteomics provides a proprietary antigen profiling and protein identification platform that analyzes patient samples to map disease-associated antigens without cloned intermediates. The company serves biotechnology and diagnostic partners by enabling target discovery, companion diagnostics development, and therapeutic selection for oncology and autoimmune diseases.
Biotechnology
cBioPortal is an open-access bioinformatics platform that enables researchers to explore, analyze, and visualize multidimensional cancer genomics data.
Similar biotech company
Verge Genomics develops a proprietary AI and machine learning platform utilizing human brain data to transform neuroscience drug discovery and precision neurology. The company provides foundation models and analytical tools to pharmaceutical and biotechnology developers for target discovery, biomarker identification, and clinical trial patient stratification.
Biotechnology
SwitchPoint Bio Holding, Inc. operates a platform that combines precision epigenomics and artificial intelligence to analyze cellular biology from blood samples. The company provides biomarker discovery, patient stratification, and treatment response mechanism readouts to support drug development and clinical research.
Similar biotech company
Form Bio is a computational life sciences company headquartered in San Carlos, California, providing AI-driven software solutions for genetic medicines and multi-species genome engineering.
Biotechnology
Biotx.ai applies large-scale Mendelian randomization and causal AI to human genetics data to map causal relationships between genes and biological outcomes. The company generates datasets and AI models that assist researchers and organizations in discovering novel drug targets and improving clinical trial design across various therapeutic areas.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Origin and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Originand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →